|
|
|
1-10 employees
View all
|
|
pharmaceuticals
|
|
20 Kingsbridge Road,Piscataway,New Jersey,US
|
|
Axcellerate is an award winning contract development and manufacturing organization (CDMO) focused on the production of Generics and Biologics. Our integrated services include: • Mammalian cell line development • Upstream and downstream process development • Fermentation * Analytical development / testing • cGMP biomanufacturing • Aseptic fill/finish (vials, syringes, lyophilization) All development activities are performed with a focus on ease of scale up to cGMP so we can efficiently take your product from development through the clinic with the ultimate goal of commercial manufacturing. Axcellerate takes pride in using a collaborative approach with our customers and providing individualized service to each customer, which is evidenced by the many industry awards we have received. We are a Commercial Manufacturer, with facilities for Vials, Syringes, High Potency,. Cytotoxic, Hormones & Steroids, Cephalosporins, with isolated buildings for handling them and isolated filling lines respectively. Our Piscataway facility: Axcellerate Pharma provides contract manufacturing and research services for the biopharmaceutical Industry. It deploys a unique combination of assets and operational capabilities to provide high quality CMO/CRO services and is ideally positioned to manufacture early cGMP clinical supplies of drug substance and sterile drug product for both large and small molecules.
|
Axcellerate Pharma LLC Email Formats | Example Email Formats | Percentage |
---|---|---|
{first}.{last} | [email protected] |
75%
|
The widely used Axcellerate Pharma LLC email format is {first}.{last} (e.g. [email protected]) with 75% adoption across the company.
To contact Axcellerate Pharma LLC customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.